Developing new statistical tools for understanding the microbiome
Collaborative Research: DMS/NIGMS 2: New statistical methods, theory, and software for microbiome data
['FUNDING_R01'] · PENNSYLVANIA STATE UNIVERSITY, THE · NIH-10919839
This study is working on new ways to analyze tiny organisms in our bodies to better understand how they affect our health, which could help create better treatments for conditions like asthma and autism.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PENNSYLVANIA STATE UNIVERSITY, THE (nih funded) |
| Locations | 1 site (UNIVERSITY PARK, UNITED STATES) |
| Trial ID | NIH-10919839 on ClinicalTrials.gov |
What this research studies
This research focuses on creating advanced statistical methods and software to analyze microbiome data, particularly from high-throughput sequencing technologies like 16S rRNA gene sequencing. By addressing the computational challenges associated with this complex data, the project aims to improve our understanding of how microbial communities impact human health and disease. Patients may benefit from these insights as they could lead to more effective microbiome-based therapies for conditions such as asthma and autism. The research will involve collaboration across large studies to ensure the methods developed are robust and applicable in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions such as asthma, autism, or other disorders potentially influenced by microbiome health.
Not a fit: Patients with conditions unrelated to microbiome health or those not participating in the studies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and interventions for various health conditions linked to the microbiome.
How similar studies have performed: Other research has shown promise in using statistical methods to analyze microbiome data, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
UNIVERSITY PARK, UNITED STATES
- PENNSYLVANIA STATE UNIVERSITY, THE — UNIVERSITY PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XUE, LINGZHOU — PENNSYLVANIA STATE UNIVERSITY, THE
- Study coordinator: XUE, LINGZHOU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autistic Disorder